Timothy P. Gilliam

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer

J.E. Stine, Hui Guo, Xiugui Sheng et al. · Oncotarget · 2015 · 92 citations · Full text

Medicine, Oncology, Pharmacology +12

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer

M. Schointuch, Timothy P. Gilliam, J.E. Stine et al. · Gynecologic Oncology · 2014 · 79 citations · Full text

Medicine, Oncology, Pharmacology +6

Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.

Hui Guo, Wei­min Kong, Lu Zhang et al. · PubMed · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer

Li Sun, Yajie Yin, Leslie H. Clark et al. · Oncotarget · 2017 · 44 citations · Full text

Medicine, Gynecology, Oncology +14

Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>.

Hannah M. Jones, Leslie H. Clark, J.E. Stine et al. · PubMed · 2017 · 44 citations

Medicine, Oncology, Pharmacology +17